You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 16, 2024

CLINICAL TRIALS PROFILE FOR IFETROBAN


✉ Email this page to a colleague

« Back to Dashboard


Clinical Trials for Ifetroban

Trial ID Title Status Sponsor Phase Summary
NCT01436500 ↗ Safety and Pharmacokinetics of Ifetroban in Hepatorenal Syndrome Patients Completed Cumberland Pharmaceuticals Phase 2 A study of ifetroban in the treatment of hepatorenal syndrome (HRS) in hospitalized adult patients to assess the safety and pharmacokinetics of 3 days of intravenous ifetroban.
NCT02216357 ↗ Trial to Determine the Safety of Oral Ifetroban in Patients With a History of Aspirin Exacerbated Respiratory Disease Completed Cumberland Pharmaceuticals Phase 2 The primary objective of the study is to determine the safety of oral ifetroban compared to placebo as measured by a > 20% decrease in FEV1 compared to baseline following a dose of Investigational Medicinal Product (IMP) (Study Day 1 or 2) prior to initiation of the aspirin challenge.
NCT02682511 ↗ Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension Recruiting Cumberland Pharmaceuticals Phase 2 The purpose of this phase 2 multicenter, randomized, double-blind, placebo-controlled, study is to assess the safety and efficacy of ifetroban in patients with diffuse cutaneous systemic SSc (dcSSc) or SSc-associated pulmonary arterial hypertension (SSc-PAH).
>Trial ID >Title >Status >Phase >Summary

Clinical Trial Conditions for Ifetroban

Condition Name

Condition Name
Intervention Trials
Asthma, Aspirin-Induced 2
Postneoadjuvant Therapy Stage II Esophageal Squamous Cell Carcinoma 1
Autoimmune Diseases 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH
Intervention Trials
Respiratory Tract Diseases 3
Respiration Disorders 3
Asthma, Aspirin-Induced 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Ifetroban

Trials by Country

Trials by Country
Location Trials
United States 57
India 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State
Location Trials
California 5
Texas 4
Ohio 4
New York 4
Indiana 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Ifetroban

Clinical Trial Phase

Clinical Trial Phase
Clinical Trial Phase Trials
Phase 2 10
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status
Clinical Trial Phase Trials
Recruiting 6
Completed 3
Not yet recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Ifetroban

Sponsor Name

Sponsor Name
Sponsor Trials
Cumberland Pharmaceuticals 9
Brigham and Women's Hospital 1
Vanderbilt University Medical Center 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type
Sponsor Trials
Industry 9
Other 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.